Amesite
AMST
12 hedge funds and large institutions have $464K invested in Amesite in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
0.08% less ownership
Funds ownership: 0.35% → 0.27% (-0.08%)
51% less capital invested
Capital invested by funds: $950K → $464K (-$486K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$64.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.6K |
| 3 |
Renaissance Technologies
New York
|
+$27.6K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$21K |
| 5 |
HF
HRT Financial
New York
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$280K |
| 2 |
Millennium Management
New York
|
-$52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$665 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $254K | +$32.6K | +3,525 | +10% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $76K | +$64.4K | +6,967 | +164% |
|
|
3
Wells Fargo
San Francisco,
California
| $57K | +$21K | +2,271 | +37% |
|
|
4
Renaissance Technologies
New York
| $27K | +$27.6K | +2,984 | +296% |
|
5
BlackRock
New York
| $22K | +$6.44K | +697 | +27% |
|
|
RJFSA
6
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $11K | – | – | – |
|
|
HF
7
HRT Financial
New York
| $9K | +$12.9K | +1,401 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $4K | +$4.01K | +434 | +232% |
|
|
9
UBS Group
Zurich,
Switzerland
| $3K | -$665 | -72 | -13% |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
ICM
11
Invenomic Capital Management
Boston,
Massachusetts
| – | -$280K | -22,643 | Closed |
|
|
12
Millennium Management
New York
| – | -$52K | -4,238 | Closed |
|
13
Morgan Stanley
New York
| – | +$9 | +1 | New |
|
|
OIA
14
Optimum Investment Advisors
Chicago,
Illinois
| – | +$74 | +8 | New |
|
AMST Hedge Fund Activity: Q1 2022 in Review
12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amesite (AMST) for Q1 2022, worth a combined $464K — down 51% from $950K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AMST positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $64.4K. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $280K sold.
- 12 institutional investors held Amesite (AMST) as of Q1 2022, up from 11 in Q4 2021.
- Funds reported $464K of Amesite stock for Q1 2022, down 51% quarter-over-quarter.
- 3 funds opened new Amesite positions in Q1 2022 and 2 closed out, a net change of +1 holder.
- The largest Amesite buyer in Q1 2022 was Geode Capital Management, an estimated $64.4K added.
- The largest Amesite seller in Q1 2022 was Invenomic Capital Management, an estimated $280K sold.
Based on aggregated 13F filings for Q1 2022.